Maverick Capital Ltd. decreased its holdings in shares of Davita Inc (NYSE:DVA) by 26.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,727 shares of the company’s stock after selling 16,379 shares during the quarter. Maverick Capital Ltd.’s holdings in Davita were worth $3,478,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in Davita by 16.8% during the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 40,917 shares of the company’s stock valued at $3,070,000 after purchasing an additional 5,900 shares during the last quarter. Northwestern Mutual Investment Management Company LLC increased its position in Davita by 33.5% during the 1st quarter. Northwestern Mutual Investment Management Company LLC now owns 4,650 shares of the company’s stock worth $354,000 after buying an additional 1,166 shares during the period. Cipher Capital LP increased its position in Davita by 10.0% during the 4th quarter. Cipher Capital LP now owns 7,017 shares of the company’s stock worth $527,000 after buying an additional 636 shares during the period. Victory Capital Management Inc. increased its position in Davita by 4,010.6% during the 1st quarter. Victory Capital Management Inc. now owns 44,600 shares of the company’s stock worth $3,392,000 after buying an additional 43,515 shares during the period. Finally, Hartford Investment Management Co. increased its position in Davita by 3.3% during the 1st quarter. Hartford Investment Management Co. now owns 9,807 shares of the company’s stock worth $746,000 after buying an additional 312 shares during the period. 91.52% of the stock is owned by institutional investors and hedge funds.
In related news, Chairman Kent J. Thiry sold 5,390 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $81.18, for a total value of $437,560.20. Following the sale, the chairman now directly owns 283,369 shares of the company’s stock, valued at $23,003,895.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Paul J. Diaz sold 5,763 shares of the firm’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $82.22, for a total value of $473,833.86. Following the completion of the sale, the director now directly owns 15,749 shares in the company, valued at $1,294,882.78. The disclosure for this sale can be found here. Insiders sold 12,109 shares of company stock worth $989,903 over the last ninety days. 1.10% of the stock is currently owned by insiders.
Shares of NYSE DVA traded down $0.67 during mid-day trading on Wednesday, reaching $78.53. The company had a trading volume of 190,303 shares, compared to its average volume of 1,432,822. The company has a debt-to-equity ratio of 5.24, a quick ratio of 1.77 and a current ratio of 1.81. Davita Inc has a one year low of $50.68 and a one year high of $90.15. The firm has a market cap of $9.62 billion, a price-to-earnings ratio of 12.42, a PEG ratio of 1.41 and a beta of 1.21. The business’s 50-day simple moving average is $80.18 and its 200 day simple moving average is $77.63.
Davita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.83 EPS for the quarter, topping the Zacks’ consensus estimate of $1.47 by $0.36. The company had revenue of $2.84 billion for the quarter, compared to analysts’ expectations of $2.84 billion. Davita had a return on equity of 32.45% and a net margin of 7.85%. Davita’s revenue was up 3.6% on a year-over-year basis. During the same quarter last year, the business earned $0.91 earnings per share. On average, sell-side analysts anticipate that Davita Inc will post 6.13 EPS for the current year.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Article: Most Active Stocks: Dollar Volume vs Share Volume
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.